NT-ProBNP antibody

Catalog No. ABIN7849774

The Goat Polyclonal anti-NT-ProBNP antibody is suitable to detect NT-ProBNP in samples from Human. It has been validated for WB, ELISA, LF and CLIA.

Quick Overview for NT-ProBNP antibody (ABIN7849774)

Target: NT-ProBNP (Pro-Brain Natriuretic Peptide (NT-ProBNP) (NT-ProBNP))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This NT-ProBNP antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Lateral Flow (LF), Chemiluminescence Immunoassay (CLIA)

Product Details anti-NT-ProBNP Antibody

Purpose: Polyclonal Anti-NT-proBNP (Capture Ab)

Specificity: It specifically recognize the human NT-proBNP, and does not cross react withcTNIand BNP.

Characteristics: This antibody may be used as Capture Ab in antibody pair experiments such as ELISA.

Purification: Protein A or G purified

Purity: >95 % by HPLC & SDS-PAGE

Immunogen: A synthetic peptide corresponding to the human NT-proBNP.

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01 M PBS ( pH 7.4) without preservative.

Preservative: Without preservative

Handling Advice: Avoid repeated freeze and thaw cycles.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C for long term (at least one year). Avoid repeated freeze and thaw cycles.

Expiry Date: 12 months

Target Details for NT-ProBNP

Target: NT-ProBNP (Pro-Brain Natriuretic Peptide (NT-ProBNP) (NT-ProBNP))

Alternative Name: NT-proBNP

Background: The N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is a 76 amino acid N-terminal fragment of brain natriuretic peptide.Both BNP and NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be useful to establish prognosis in heart failure, as both markers are typically higher in patients with worse outcome.BNP may be a useful screening tool for left ventricular dysfunction in patients with history suggestive of heart disease and be used to assist in forming a pretest probability, which in turn could greatly assist in appropriateness of patient referral and in optimization of drug therapy.